Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
3 other identifiers
observational
50
1 country
1
Brief Summary
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2000
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2000
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedApril 22, 2010
April 1, 2010
3.1 years
September 12, 2005
April 20, 2010
Conditions
Eligibility Criteria
Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Stanford, California, 94305, United States
Biospecimen
blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Quynh-Thu Le
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 16, 2005
Study Start
September 1, 2000
Primary Completion
October 1, 2003
Study Completion
May 1, 2008
Last Updated
April 22, 2010
Record last verified: 2010-04